CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
Key figures
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $68M | −21.1% |
| Operating income | −$708M | — |
| Net income | −$894M | — |
| EPS | −$7.23 | — |
| Free cash flow | −$581M | — |
Cytokinetics, Incorporated
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Metric | TTM | YoY |
|---|---|---|
| Revenue | $68M | −21.1% |
| Operating income | −$708M | — |
| Net income | −$894M | — |
| EPS | −$7.23 | — |
| Free cash flow | −$581M | — |